Correlation of C0 and C2 Levels With Lipid Profiles in Adolescent Renal Transplant Recipients in the Early and Late Posttransplant Periods

作者: A. Soylu , S. Kavukçu , M.A. Türkmen , B. Kasap , A. Soylu

DOI: 10.1016/J.TRANSPROCEED.2006.02.073

关键词: HypertriglyceridemiaCreatinineTransplantationHyperlipidemiaKidney transplantationMedicineInternal medicineBlood lipidsChronic allograft nephropathyUrinary systemGastroenterologyEndocrinology

摘要: Hyperlipidemia is a frequent complication after renal transplantation. Cyclosporine therapy an important cause of hyperlipidemia. It still controversial whether C0 or C2 the most effective way to monitor blood cyclosporine concentrations guide dosages. We sought evaluate relationship serum lipid levels in early and late posttransplant periods among adolescent transplant recipients. The posttransplantation charts 26 recipients were evaluated retrospectively. Serum (triglyceride total cholesterol) analyzed both (first 6 months) (thereafter) periods. Hypertriglyceridemia hypercholesterolemia defined as above 95th percentile adjusted for age gender. To influence on lipids, we excluded one patient with familial In addition, remaining 25 patients acute rejection when creatinine 2.5 mg/dL, representing chronic allograft nephropathy. Concurrently recorded present only 21 patients. Overall, records 245 visits these incidence hyperlipidemia decreased period, being significant hypercholesterolemia. had strong negative correlation lipids; it was cholesterol period (r=-0.542, P=.005), but weaker whole Thus lipids showed differences during follow-up. C0, other hand, positively correlated all periods, (r=0.293, P=.000) (r=0.196, P=.025). Although not statistically significant, higher hypertriglyceridemic hypercholesterolemic episodes When (789 visits), (P=.013, r=0.198 P=.000, r=0.177, respectively). concluded that has more predictable transplantation

参考文章(17)
Hal B. Jenson, [edited by] Richard E. Behrman, Robert M. Kliegman, Nelson textbook of pediatrics ,(1945)
C E Cronk, A F Roche, Reference data for obesity. The American Journal of Clinical Nutrition. ,vol. 54, pp. 953- 954 ,(1991) , 10.1093/AJCN/54.5.953
Salih Kavukçu, Alper Soylu, Mehmet Türkmen, Belde Kasap, Mukaddes Gümüştekin, Hüseyin Gülay, None, Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period. Pediatric Nephrology. ,vol. 19, pp. 667- 671 ,(2004) , 10.1007/S00467-004-1452-X
L. Lőcsey, L. Asztalos, Zs. Kincses, Cs. Berczi, Gy. Paragh, The importance of obesity and hyperlipidaemia in patients with renal transplants International Urology and Nephrology. ,vol. 30, pp. 767- 775 ,(1998) , 10.1007/BF02564866
Brian W. McCrindle, Hyperlipidemia in children. Thrombosis Research. ,vol. 118, pp. 49- 58 ,(2006) , 10.1016/J.THROMRES.2005.01.006
H Cardinal, A.A Barama, V Fradet, M Lallier, R Lévesque, G St Louis, M.J Hébert, C Girardin, M Pâquet, P Daloze, Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression. Transplantation proceedings. ,vol. 36, pp. 448- 450 ,(2004) , 10.1016/J.TRANSPROCEED.2004.01.053
I.E Willetts, R.S Trompeter, Experience with cyclosporine in pediatric renal transplantation Transplantation Proceedings. ,vol. 36, pp. 211- 215 ,(2004) , 10.1016/J.TRANSPROCEED.2004.01.047
GABRIELA M. KUSTER, HEINZ DREXEL, JÖRG A. BLEISCH, KATHARINA RENTSCH, PATRICK PEI, ULRICH BINSWANGER, AND FRANZ W. AMANN, Relation Of Cyclosporine Blood Levels To Adverse Effects On Lipoproteins Transplantation. ,vol. 57, pp. 1479- 1483 ,(1994) , 10.1097/00007890-199405000-00014
Tomoki Okuda, Tsunao Oh-i, Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-destiny lipoprotein European Journal of Clinical Pharmacology. ,vol. 58, pp. 299- 300 ,(2002) , 10.1007/S00228-002-0524-8
Anup Singh, Amir Tejani, Hyperlipidemia in Children: The Role of Uremia, Steroids and Cyclosporine Therapy Nephron. ,vol. 74, pp. 529- 535 ,(1996) , 10.1159/000189447